AndreaBozzo/ceres-open-data-index huggingface dataset:
Prevention Quality Indicator (PQI) Composite Measure Rates by County, 2008-2015

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024

Rate per 100,000; rates are adjusted for age and sex.

PQI measures are used to monitor performance over time or across regions and populations using patient data found in a typical hospital discharge abstract. PQI measures can be used to summarize quality across multiple indicators, improve ability to detect differences, identify important domains and drivers of quality, prioritize action for quality improvement, make current decisions about future and unknown health care needs. 
Overall Composite (PQI #90) is comprised of: all PQI measures within the Chronic and Acute Composites.

Chronic Composite (PQI #92) is comprised of: PQI #01 Diabetes Short-Term Complications Admission Rate, PQI #03 Diabetes Long-Term Complications Admission Rate, PQI #05 Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate, PQI #07 Hypertension Admission Rate, PQI #08 Congestive Heart Failure (CHF) Admission Rate, PQI #13 Angina without Procedure Admission Rate, PQI #14 Uncontrolled Diabetes Admission Rate, PQI #15 Asthma in Younger Adults Admission Rate, PQI #16 Rate of Lower-Extremity Amputation Among Patients With Diabetes, 

Acute Composite (PQI #91) is comprised of: PQI #10 Dehydration Admission Rate, PQI #11 Bacterial Pneumonia Admission Rate, and PQI #12 Urinary Tract Infection Admission Rate.

NOTE: PQI Version Change in 2012. Previous numbers for 2012 have been overwritten. Trends may not be accurate between 2011 and 2012.
Patent AT-E399862-T1: [Translated] HUMAN NUCLEIC ACID SEQUENCE FROM PROSTATE TUMOR TISSUE

Nucleic acid sequences (A) that are expressed at high level in prostatic tumor tissue and encode gene products or their fragments are new. (A) is: (a) one of 54 sequences (all reproduced), all fully defined in the specification; (b) allelic variants of 38 of these sequences; or (c) the complements of these 38 sequences. Independent claims are also included for the following: (1) bacterial or phage artificial chromosomes, or cosmid clones, containing functional genes and their chromosomal locations corresponding to (A), for use as gene transfer vehicles; (2) fragments of (A) large enough to hybridize to (A); (3) expression cassette (EC) comprising (A), or its fragments, plus at least one control or regulatory element; (4) DNA fragments containing a gene obtained using (A); (5) host cells containing (A) or its fragments as a heterologous component of the genome; (6) recombinant production of polypeptides (I), or their fragments, by culturing these cells; (7) antibodies (Ab) directed against (I) or its fragments; (8) 74 polypeptide partial sequences (I), all reproduced, and sequences at least 80 (especially 90) % homologous with them; (9) a pharmaceutical composition containing at least one (I); and (10) genomic genes, their promoters, enhancers, silencers, exon or intron structures, or slice variants, obtained using (A).
Socio-demographic factors and self-reported funtional status: the significance of social support

Background
          The aim of the present work was to investigate the relative importance of socio-demographic and physical health status factors for subjective functioning, as well as to examine the role of social support.
        
        
          Methods
          A cross-sectional health survey was carried out in a Greek municipality. 1356 adults of the general population were included in the study. Personal interviews were conducted with house-to-house visits. The response rate was 91.2%. Functioning has been measured by five indexes: 'The Social Roles and Mobility' scale (SORM), 'The Self-Care Restrictions' scale (SCR), 'The Serious Limitations' scale (SL), 'The Minor Self-care Limitations' scale (MSCR) and 'The Minor Limitations in Social Roles and Mobility' scale (MSORM).
        
        
          Results
          Among the two sets of independent variables, the socio-demographic ones had significant influence on the functional status, except for MSORM. Allowing for these variables, the physical health status indicators had also significant effects on all functioning scales. Living arrangements and marital status had significant effects on four out of five indexes, while arthritis, Parkinson's disease, past stroke and kidney stones had significant effects on the SCR and SL scales.
        
        
          Conclusions
          These results suggest that socio-demographic factors are as important as physical health variables in affecting a person's ability to function normally in their everyday life. Social support appears to play a significant role in explaining differences in subjective functioning: people living alone or only with the spouse, particularly the elderly, seem to be in greater risk for disability problems and should be targeted by preventive programs in the community.
Genomic organization and single-nucleotide polymorphism map of desmuslin, a novel intermediate filament protein on chromosome 15q26.3

Background
          Desmuslin is an α-dystrobrevin-interacting protein expressed primarily in heart and skeletal muscle. The desmuslin protein interacts with and is closely related to desmin, a protein encoded by a locus mutated in some forms of hereditary distal myopathy. As a muscle-specific intermediate filament protein, desmuslin is also a candidate for myopathies of unknown etiology.
        
        
          Results
          The desmuslin gene was localized to chromosome 15q26.3 by electronic screening of the human DNA sequence database. Primer pairs were designed to amplify the 5 exons of the desmuslin gene in 11 overlapping DNA segments. The desmuslin gene was screened for mutations in 71 patients with various forms of myopathy for which there was no known cause. In this analysis, 10 common and 2 rare amino acid altering single-nucleotide polymorphisms were identified, all of which were seen in a control population of individuals thus making these unlikely causes of the phenotype. Interestingly, one of the single-nucleotide polymorphisms found in a patient resulted in a premature stop codon in the first exon. The nonsense mutation was also detected in the patient's unaffected father and one unaffected control; it was detected in 0.44% (2/454) of unrelated chromosomes and is therefore predicted to have a homozygous frequency of 0.002%.
        
        
          Conclusion
          No causative mutations were found in the desmuslin gene. However, the single-nucleotide polymorphisms mapped in this study represent a well-mapped group that can be used for disequilibrium studies of this region of chromosome 15q26.3.
Current perspectives on synovitis

The synovium lines the noncartilaginous surfaces of the diarthrodial		  joints, and synovial tissue is also found in tendon sheaths and bursae [1]. Several rheumatic diseases are characterized by synovial		  inflammation. In these conditions, descriptive studies of synovial biopsy		  specimens may contribute to an understanding of the events that take placein vivo, and they complement experimental animal studies as well as		  in-vitro studies. Examination of synovial tissue is generally more relevant		  than synovial fluid analysis, except, for example, the analysis of neutrophils		  and platelets, and studies of soluble mediators. Recently, there has been an		  enormous upsurge in investigations of the pathological changes in the synovium		  [2] because of the availability of new methods to obtain		  synovial biopsy samples [3,4] and		  because of the development of immunohistological methods, in-situ		  hybridization, and the polymerase chain reaction. Moreover, the complementary		  DNA microarray technology may hold great promise for synovial tissue analysis		  in the future [5].
Patent AT-E400605-T1: [Translated] ORGANIC/INORGANIC NANOCOMPOSITE ITEMS AVAILABLE BY EXTRUSION

Organic/inorganic nanocomposites and methods for their preparation are disclosed. In one embodiment, the method comprises the steps of providing an organic/inorganic concentrate and processing the concentrate with a polymer resin. In a preferred embodiment the organic/inorganic concentrate and polymer resin are processed by extrusion using a single-screw extruder. In another embodiment, the method further comprises surface modifying an inorganic additive, mixing the modified additive with a polymer solution to produce an organic/inorganic solution, and removing solvent from the organic/inorganic solution to produce the organic/inorganic concentrate. Processing of the organic/inorganic concentrate with a polymer resin produces a homogeneous nanocomposite with superior mechanical and thermal properties.
Compound 528553: Octadecane, 2,6,10,15-tetramethyl

Chemical compound data from PubChem database. IUPAC Name: 2,6,10,15-tetramethyloctadecane. Molecular Formula: C22H46. Molecular Weight: 310.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525053: 1-Heptanamine, 1-methyl, N-ethyl

Chemical compound data from PubChem database. IUPAC Name: N-ethyloctan-2-amine. Molecular Formula: C10H23N. Molecular Weight: 157.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Isozyme and allozyme markers distinguishing two morphologically similar, medically important

Background
          Two common southern African mice species, Mastomys coucha and M. natalensis, are widely distributed throughout the subregion and overlap in many areas. They also share a high degree of morphological similarity, making them impossible to distinguish in the field at present. These multimammate mice are documented carriers of serious disease vectors causing Lassa fever, plague and encephalomyocarditis, which coupled to their cohabitation with humans in many areas, could pose a significant health risk. A preliminary study reported the presence of isozyme markers at three loci (GPI-2, PT-2, -3) in one population each of M. coucha and M. natalensis. Two additional populations (from the Vaal Dam and Richards Bay) were sampled to determine the reliability of these markers, and to seek additional genetic markers.
        
        
          Results
          Fifteen proteins or enzymes provided interpretable results at a total of 39 loci. Additional fixed allele differences between the species were detected at AAT-1, ADH, EST-1, PGD-1, Hb-1 and -2. Average heterozygosities for M. coucha and M. natalensis were calculated as 0.018 and 0.032 respectively, with a mean genetic distance between the species of 0.26.
        
        
          Conclusions
          The confirmation of the isozyme and the detection of the additional allozyme markers are important contributions to the identification of these two medical and agricultural pest species.
Patent AT-E401202-T1: [Translated] METHOD FOR PROTECTING A PRINTED PRODUCT

The invention provides a coating implement for applying a nonvolatile liquid for protection treatment, which does not dissolve a coloring material, to a recorded product which is provided with a porous layer as an ink-receiving layer on the surface of a substrate, and on which an image has been formed with the coloring material adsorbed on at least the porous layer, thereby protecting the image, wherein a coating surface for applying the liquid to the porous layer having the image is supported by a supporting member, and the coating surface can hold the liquid.
autism prevalence studies

This data table provides a collection of information from peer-reviewed autism prevalence studies. Information reported from each study includes the autism prevalence estimate and additional study characteristics (e.g., case ascertainment and criteria). A PubMed search was conducted to identify studies published at any time through September 2020 using the search terms: autism (title/abstract) OR autistic (title/abstract) AND prevalence (title/abstract). Data were abstracted and included if the study fulfilled the following criteria: 
•	The study was published in English; 
•	The study produced at least one autism prevalence estimate; and
•	The study was population-based (any age range) within a defined geographic area.
Patent AT-E400001-T1: [Translated] METHOD FOR IMPROVING THE DEPTH DISCRIMINATION OF OPTICAL IMAGING SYSTEMS

The invention is directed to a method for improving the depth discrimination in optically imaging systems. It is applicable in particular in light microscopy for improving image quality when examining three-dimensionally extending objects. It is applicable in the method of structured illumination as described in WO 97/6509. For this purpose, influences due to variations in the brightness of the light source, positioning of the imaged periodic structure and bleaching of the object in fluorescence illumination are determined and taken into account in the calculation of the object structure.
NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis

NNDSS - TABLE 1AA. Poliovirus infection, nonparalytic to Psittacosis - 2022. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notes:

•	These are weekly cases of selected infectious national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables available at https://www.cdc.gov/nndss/data-statistics/index.html. Cases reported by state health departments to CDC for weekly publication are subject to ongoing revision of information and delayed reporting. Therefore, numbers listed in later weeks may reflect changes made to these counts as additional information becomes available. Case counts in the tables are presented as published each week. See also Guide to Interpreting Provisional and Finalized NNDSS Data at https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
• Notices, errata, and other notes are available in the Notice To Data Users page at https://wonder.cdc.gov/nndss/NTR.html.
•	The list of national notifiable infectious diseases and conditions and their national surveillance case definitions are available at https://ndc.services.cdc.gov/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved by CSTE for national surveillance.

Footnotes:

*Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
Mental Health Service Use Of Youth Leaving Foster Care (Voyages) 2001-2003

The study was funded to explore the changes in mental health service use as older youth leave the foster care system. The data, however, examine many parameters of the lives of older youth in the foster care system, from their perspective. Four-hundred six youth in the Missouri foster care system were interviewed in person near their 17th birthday. They were re-interviewed when possible every three months until their 19th birthday. Eighty percent of the youth were interviewed at age 19. Thus, the study includes nine data points.  Domains of instrumentation include psychiatric history, substance use, child maltreatment history, mental health service use, attitudes toward mental health service use, residential history, religious involvement, reading level, dating violence, trauma history, stress, perception of neighborhood, psychopathy, employment, legal involvement, childbearing, sexual activity, and much more. Few variables were assessed at each interview time point.

Investigators: Curtis McMillen, Ph.D.
Washington University St. Louis, MO

Lionel D Scott, Ph.D.Huntsville, AL


Wendy Fran Auslander, Ph.D.
Washington University ST. Louis, MI
The baboon (

Background
          As novel endovascular strategies are developed for treating neurological disease, there is an increasing need to evaluate these techniques in relevant preclinical models. The use of non-human primates is especially critical given their structural and physiological homology with humans. In order to conduct primate endovascular studies, a comprehensive understanding of the carotid anatomy is necessary. We therefore performed a detailed examination of the vessel lengths, lumen diameters and angles of origin of the baboon extracranial carotid system.
        
        
          Methods
          We characterized the extracranial carotid system often male baboons (Papio anubis, range 15.1–28.4 kg) by early post-mortem dissection. Photographic documentation of vessel lengths, lumen diameters, and angles of origin were measured for each segment of the carotid bilaterally.
        
        
          Results
          The common carotid arteries averaged 94.7 ± 1.7 mm (left) and 87.1 ± 1.6 mm (right) in length. The average minimal common carotid lumen diameters were 3.0 ± 0.3 mm (left) and 2.9 ± 0.2 mm (right). Each animal had a common brachiocephalic artery arising from the aorta which bifurcated into the left common carotid artery and right braciocephalic artery after 21.5 ± 1.6 mm. The vascular anatomy was found to be consistent among animals despite a wide range of animal weights.
        
        
          Conclusions
          The consistency in the Papio anubis extracranial carotid system may promote the use of this species in the preclinical investigation of neuro-interventional therapies.
Compound 527491: Isokessane

Chemical compound data from PubChem database. IUPAC Name: 1,5,9,9-tetramethyl-10-oxatricyclo[6.2.2.02,6]dodecane. Molecular Formula: C15H26O. Molecular Weight: 222.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
MD COVID-19 - Vaccinations by County

Regarding all Vaccination Data
The date of Last Update is 4/21/2023. Additionally on 4/27/2023 several COVID-19 datasets were retired and no longer included in public COVID-19 data dissemination.

See this link for more information
https://imap.maryland.gov/pages/covid-data

<b>Summary</b>
The cumulative number of COVID-19 vaccinations within a single Maryland jurisdiction.

<b>Description</b>
The MD COVID-19 - Vaccinations by County data layer is a collection of COVID-19 vaccinations that have been reported each day into ImmuNet.

<b>Terms of Use</b>
The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. 

The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
2010 CMHS Uniform Reporting System (URS) Output Tables for West Virginia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Engaging Fathers Part 2

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
2014 CMHS Uniform Reporting System (URS) Table for Missouri

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Missouri. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Child and Youth Connections: Results From CFSR Round 3 (2015-2018)

This report uses Round 3 (2015—2018) CFSR results to understand how, how often, and how well child welfare systems helped to promote and preserve children’s connections in four areas: with parents; with siblings; with extended family; and with children’s community, culture, school, and friends. In each area, data from Round 3 of the CFSRs provides information about state child welfare systems.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E400435-T1: [Translated] PAINT CHAMBER SQUEEGEE

The invention relates to a color chamber doctor blade 1 , which has following characteristic features: two doctor blade knives 2 that can be set up in a roof-like fashion against a roller 6 from which two doctor blade knives 2 can be fixed on the doctor blade chamber body 5 by means of a clamping plate 3 whereby the clamping plate 3 is in active connection with long-stretch fasteners 4 in the axial direction (z) of the roller 6, which are arranged essentially parallel to the clamping plate 3 and from which the force required for fixing at least one doctor blade knife 2 is applied. Inventive is that the resultant of the force exercised by the fasteners 4 points to the doctor blade chamber body 5.
Compound 530681: 4-Ethylbenzoic acid, 3-methylbut-2-enyl ester

Chemical compound data from PubChem database. IUPAC Name: 3-methylbut-2-enyl 4-ethylbenzoate. Molecular Formula: C14H18O2. Molecular Weight: 218.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.